{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T19:57:23Z","timestamp":1787860643995,"version":"build-2784847793"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The present study aims to develop and characterize cannabidiol (CBD) solid dispersions using Vacuum Compression Molding (VCM) to enhance the drug solubility and release profile. Solid dispersions of CBD and polymers were processed using VCM at 130\u00a0\u00b0C for 4\u00a0min after a prior physical mixing. Five percent w\/w of CBD was used with 5% w\/w of poloxamer 188 and 90% w\/w of polymeric carrier (Polyethylene Oxide, PEO-N80 or Hydroxypropyl cellulose, HPCEF). Discs were collected and milled to obtain formulations (F1V, F2V). The degradation temperature of CBD was determined using Thermogravimetric Analysis (TGA). The formulations were further characterized using differential scanning calorimetry (DSC), scanning electron microscopy (SEM), and Fourier-Transform Infrared Spectroscopy (FTIR). <jats:italic>In vitro<\/jats:italic> dissolution testing of pure CBD and formulations was evaluated using USP apparatus II. TGA showed that CBD degradation occurs after 200\u00a0\u00b0C. FTIR spectra of formulations indicate potential interactions between the drug and polymers. DSC thermograms of F1V showed a thermal peak at 65\u00a0\u00b0C that could correspond to PEO-N80. F2V did not show any of the thermal event peaks, which suggests the conversion of the drug to the amorphous state. Images from the SEM showed irregular surfaces for both formulations. The release profile showed an increase in the CBD dissolution rate by 4.75 folds for F1V and 3.63 folds for F2V in four hours. In this study, solid dispersions of CBD formulations were successfully achieved. The VCM technology has proven to be successful in formulating solid dispersions of CBD for early-stage drug development.<\/jats:p>\n          <jats:p>\n            <jats:bold>Graphical Abstract<\/jats:bold>\n          <\/jats:p>","DOI":"10.1208\/s12249-025-03078-8","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T21:33:31Z","timestamp":1741728811000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Towards Enhanced Solubility of Cannabidiol: Preparation and Evaluation of Cannabidiol Solid Dispersions Using Vacuum Compression Molding"],"prefix":"10.1208","volume":"26","author":[{"given":"Achref","family":"Cherif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janhavi","family":"Deshmukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavish","family":"Sanil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman","family":"Taha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Treffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9013-1327","authenticated-orcid":false,"given":"Eman A.","family":"Ashour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,11]]},"reference":[{"key":"3078_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.103372","volume":"71","author":"O Jennotte","year":"2022","unstructured":"Jennotte O, Koch N, Lechanteur A, Evrard B. Development of amorphous solid dispersions of cannabidiol: Influence of the carrier, the hot-melt extrusion parameters and the use of a crystallization inhibitor. J Drug Deliv Sci Technol. 2022;71: 103372.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"3","key":"3078_CR2","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s40429-020-00326-8","volume":"7","author":"DJ Sholler","year":"2020","unstructured":"Sholler DJ, Schoene L, Spindle TR. Therapeutic efficacy of cannabidiol (CBD): A review of the evidence from clinical trials and human laboratory studies. Curr Addict Rep. 2020;7(3):405\u201312.","journal-title":"Curr Addict Rep"},{"key":"3078_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.906038","volume":"13","author":"A Salehi","year":"2022","unstructured":"Salehi A, Puchalski K, Shokoohinia Y, Zolfaghari B, Asgary S. Differentiating Cannabis Products: Drugs, Food, and Supplements. Front Pharmacol. 2022;13: 906038.","journal-title":"Front Pharmacol"},{"key":"3078_CR4","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.3389\/fphar.2018.01365","volume":"9","author":"SA Millar","year":"2018","unstructured":"Millar SA, Stone NL, Yates AS, O\u2019Sullivan SE. A systematic review on the pharmacokinetics of cannabidiol in humans. Front Pharmacol. 2018;9:1365.","journal-title":"Front Pharmacol"},{"issue":"6","key":"3078_CR5","first-page":"485","volume":"25","author":"R Abu-Sawwa","year":"2020","unstructured":"Abu-Sawwa R, Scutt B, Park Y. Emerging use of epidiolex (Cannabidiol) in Epilepsy. J Pediatr Pharmacol Ther JPPT. 2020;25(6):485\u201399.","journal-title":"J Pediatr Pharmacol Ther JPPT"},{"issue":"5","key":"3078_CR6","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1517\/14656566.7.5.607","volume":"7","author":"MP Barnes","year":"2006","unstructured":"Barnes MP. Sativex: clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain. Expert Opin Pharmacother. 2006;7(5):607\u201315.","journal-title":"Expert Opin Pharmacother"},{"key":"3078_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.msard.2017.06.015","volume":"17","author":"S Giacoppo","year":"2017","unstructured":"Giacoppo S, Bramanti P, Mazzon E. Sativex in the management of multiple sclerosis-related spasticity: An overview of the last decade of clinical evaluation. Mult Scler Relat Disord. 2017;17:22\u201331.","journal-title":"Mult Scler Relat Disord"},{"key":"3078_CR8","first-page":"106058","volume":"168","author":"LY Kok","year":"2022","unstructured":"Kok LY, Bannigan P, Sanaee F, Evans JC, Dunne M, Regenold M, et al. Development and pharmacokinetic evaluation of a self-nanoemulsifying drug delivery system for the oral delivery of cannabidiol. Eur J Pharm Sci Off J Eur Fed Pharm Sci. 2022;168:106058.","journal-title":"Eur J Pharm Sci Off J Eur Fed Pharm Sci"},{"key":"3078_CR9","doi-asserted-by":"publisher","first-page":"119812","DOI":"10.1016\/j.ijpharm.2020.119812","volume":"589","author":"N Koch","year":"2020","unstructured":"Koch N, Jennotte O, Gasparrini Y, Vandenbroucke F, Lechanteur A, Evrard B. Cannabidiol aqueous solubility enhancement: Comparison of three amorphous formulations strategies using different type of polymers. Int J Pharm. 2020;589:119812.","journal-title":"Int J Pharm"},{"issue":"19","key":"3078_CR10","doi-asserted-by":"publisher","first-page":"14514","DOI":"10.3390\/ijms241914514","volume":"24","author":"KR Hossain","year":"2023","unstructured":"Hossain KR, Alghalayini A, Valenzuela SM. Current challenges and opportunities for improved cannabidiol solubility. Int J Mol Sci. 2023;24(19):14514.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"3078_CR11","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1208\/s12249-024-02857-z","volume":"25","author":"K Sanil","year":"2024","unstructured":"Sanil K, Almotairy A, Uttreja P, Ashour EA. Formulation development and evaluation of cannabidiol hot-melt extruded solid self-emulsifying drug delivery system for oral applications. AAPS PharmSciTech. 2024;25(5):136.","journal-title":"AAPS PharmSciTech"},{"issue":"5","key":"3078_CR12","first-page":"148","volume":"3","author":"J Singh","year":"2013","unstructured":"Singh J, Walia M, Harikumar SL. Solubility enhancement by solid dispersion method: a review. J Drug Deliv Ther. 2013;3(5):148\u201355.","journal-title":"J Drug Deliv Ther"},{"issue":"10","key":"3078_CR13","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.1002\/jps.24541","volume":"104","author":"Y He","year":"2015","unstructured":"He Y, Ho C. Amorphous solid dispersions: utilization and challenges in drug discovery and development. J Pharm Sci. 2015;104(10):3237\u201358.","journal-title":"J Pharm Sci"},{"key":"3078_CR14","doi-asserted-by":"crossref","unstructured":"Vasconcelos T, Marques S, das Neves J, Sarmento B. Amorphous solid dispersions: Rational selection of a manufacturing process. Adv Drug Deliv Rev. 2016;100:85\u2013101.","DOI":"10.1016\/j.addr.2016.01.012"},{"issue":"1\u20132","key":"3078_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2003.11.025","volume":"272","author":"S Sethia","year":"2004","unstructured":"Sethia S, Squillante E. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. Int J Pharm. 2004;272(1\u20132):1\u201310.","journal-title":"Int J Pharm"},{"issue":"5","key":"3078_CR16","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.ejps.2011.10.008","volume":"44","author":"JX Wu","year":"2011","unstructured":"Wu JX, Yang M, van den Berg F, Pajander J, Rades T, Rantanen J. Influence of solvent evaporation rate and formulation factors on solid dispersion physical stability. Eur J Pharm Sci. 2011;44(5):610\u201320.","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"3078_CR17","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ijpharm.2005.05.017","volume":"301","author":"DH Won","year":"2005","unstructured":"Won DH, Kim MS, Lee S, Park JS, Hwang SJ. Improved physicochemical characteristics of felodipine solid dispersion particles by supercritical anti-solvent precipitation process. Int J Pharm. 2005;301(1):199\u2013208.","journal-title":"Int J Pharm"},{"issue":"12","key":"3078_CR18","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1023\/A:1012167410376","volume":"14","author":"LS Taylor","year":"1997","unstructured":"Taylor LS, Zografi G. Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm Res. 1997;14(12):1691\u20138.","journal-title":"Pharm Res"},{"key":"3078_CR19","doi-asserted-by":"crossref","unstructured":"Huang S, O\u2019Donnell KP, Delpon de Vaux SM, O\u2019Brien J, Stutzman J, Williams RO. Processing thermally labile drugs by hot-melt extrusion: The lesson with gliclazide. Eur J Pharm Biopharm. 2017;119:56\u201367.","DOI":"10.1016\/j.ejpb.2017.05.014"},{"issue":"10","key":"3078_CR20","doi-asserted-by":"publisher","first-page":"3620","DOI":"10.1021\/ma9002769","volume":"42","author":"M Bercea","year":"2009","unstructured":"Bercea M, Eckelt J, Morariu S, Wolf BA. Islands of immiscibility for solutions of compatible polymers in a common solvent: experiment and theory. Macromolecules. 2009;42(10):3620\u20136.","journal-title":"Macromolecules"},{"issue":"1","key":"3078_CR21","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/jps.24262","volume":"104","author":"JT Morott","year":"2015","unstructured":"Morott JT, Pimparade M, Park JB, Worley CP, Majumdar S, Lian Z, et al. The effects of screw configuration and polymeric carriers on hot-melt extruded taste-masked formulations incorporated into orally disintegrating tablets. J Pharm Sci. 2015;104(1):124\u201334.","journal-title":"J Pharm Sci"},{"issue":"2","key":"3078_CR22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1080\/00222347608212770","volume":"12","author":"PH Geil","year":"1976","unstructured":"Geil PH. Morphology of amorphous polymers. J Macromol Sci Part B. 1976;12(2):173\u2013208.","journal-title":"J Macromol Sci Part B"},{"issue":"1","key":"3078_CR23","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1208\/s12249-015-0360-7","volume":"17","author":"H Patil","year":"2016","unstructured":"Patil H, Tiwari RV, Repka MA. Hot-melt extrusion: from theory to application in pharmaceutical formulation. AAPS PharmSciTech. 2016;17(1):20\u201342.","journal-title":"AAPS PharmSciTech"},{"issue":"3","key":"3078_CR24","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1517\/17425247.2016.1126246","volume":"13","author":"RV Tiwari","year":"2016","unstructured":"Tiwari RV, Patil H, Repka MA. Contribution of hot-melt extrusion technology to advance drug delivery in the 21st century. Expert Opin Drug Deliv. 2016;13(3):451\u201364.","journal-title":"Expert Opin Drug Deliv"},{"issue":"1","key":"3078_CR25","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.ijpharm.2012.11.001","volume":"453","author":"S Shah","year":"2013","unstructured":"Shah S, Maddineni S, Lu J, Repka MA. Melt extrusion with poorly soluble drugs. Int J Pharm. 2013;453(1):233\u201352.","journal-title":"Int J Pharm"},{"key":"3078_CR26","first-page":"e436763","volume":"2012","author":"M Maniruzzaman","year":"2012","unstructured":"Maniruzzaman M, Boateng JS, Snowden MJ, Douroumis D. A review of hot-melt extrusion: process technology to pharmaceutical products. Int Sch Res Not. 2012;2012:e436763.","journal-title":"Int Sch Res Not"},{"key":"3078_CR27","doi-asserted-by":"publisher","first-page":"101459","DOI":"10.1016\/j.jddst.2019.101459","volume":"55","author":"N Mendonsa","year":"2020","unstructured":"Mendonsa N, Almutairy B, Kallakunta VR, Sarabu S, Thipsay P, Bandari S, et al. Manufacturing strategies to develop amorphous solid dispersions: An overview. J Drug Deliv Sci Technol. 2020;55:101459.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"5","key":"3078_CR28","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1208\/s12249-018-1007-2","volume":"19","author":"DJ Ellenberger","year":"2018","unstructured":"Ellenberger DJ, Miller DA, Williams RO. Expanding the application and formulation space of amorphous solid dispersions with KinetiSol\u00ae: a review. AAPS PharmSciTech. 2018;19(5):1933\u201356.","journal-title":"AAPS PharmSciTech"},{"issue":"8","key":"3078_CR29","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1016\/j.apsb.2021.05.014","volume":"11","author":"SV Bhujbal","year":"2021","unstructured":"Bhujbal SV, Mitra B, Jain U, Gong Y, Agrawal A, Karki S, Taylor LS, Kumar S, Tony ZQ. Pharmaceutical amorphous solid dispersion: A review of manufacturing strategies. Acta Pharm Sin B. 2021;11(8):2505\u201336.","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"3078_CR30","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ijpharm.2014.03.022","volume":"466","author":"D Treffer","year":"2014","unstructured":"Treffer D, Wahl PR, H\u00f6rmann TR, Markl D, Schrank S, Jones I, et al. In-line implementation of an image-based particle size measurement tool to monitor hot-melt extruded pellets. Int J Pharm. 2014;466(1):181\u20139.","journal-title":"Int J Pharm"},{"key":"3078_CR31","doi-asserted-by":"crossref","unstructured":"ramb\u00f6ck, A., Treffer, D. (2024). Free-D Molding: Every Idea Deserves a Prototype. In: Repka, M.A., Langley, N. (eds) 3D Printing . AAPS Advances in the Pharmaceutical Sciences Series, vol 44. Springer, Cham.","DOI":"10.1007\/978-3-031-46015-9_9"},{"key":"3078_CR32","doi-asserted-by":"publisher","first-page":"123952","DOI":"10.1016\/j.ijpharm.2024.123952","volume":"654","author":"G Dhumal","year":"2024","unstructured":"Dhumal G, Treffer D, Polli JE. Concordance of vacuum compression molding with spray drying in screening of amorphous solid dispersions of itraconazole. Int J Pharm. 2024;654:123952.","journal-title":"Int J Pharm"},{"key":"3078_CR33","unstructured":"MeltPrep HME ASD Hot Melt Extrusion - HME Screening via VCM | MeltPrep. Available from: https:\/\/www.meltprep.com\/vcm. Accessed 9 Mar 2024."},{"issue":"11","key":"3078_CR34","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.3390\/pharmaceutics12111019","volume":"12","author":"G Shadambikar","year":"2020","unstructured":"Shadambikar G, Kipping T, Di-Gallo N, Elia AG, Kn\u00fcttel AN, Treffer D, et al. Vacuum compression molding as a screening tool to investigate carrier suitability for hot-melt extrusion formulations. Pharmaceutics. 2020;12(11):1019.","journal-title":"Pharmaceutics"},{"issue":"6","key":"3078_CR35","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1002\/jps.23978","volume":"103","author":"P Macfhionnghaile","year":"2014","unstructured":"Macfhionnghaile P, Hu Y, Gniado K, Curran S, Mcardle P, Erxleben A. Effects of ball-milling and cryomilling on sulfamerazine polymorphs: a quantitative study. J Pharm Sci. 2014;103(6):1766\u201378.","journal-title":"J Pharm Sci"},{"issue":"7","key":"3078_CR36","doi-asserted-by":"publisher","first-page":"934","DOI":"10.3390\/ph17070934","volume":"17","author":"D Hales","year":"2024","unstructured":"Hales D, Bogdan C, Tefas LR, Cornil\u0103 A, Chiver MA, Tomu\u021b\u0103 I, et al. Exploring vacuum compression molding as a preparation method for flexible-dose pediatric orodispersible films. Pharmaceuticals. 2024;17(7):934.","journal-title":"Pharmaceuticals"},{"issue":"4","key":"3078_CR37","doi-asserted-by":"publisher","first-page":"e1091","DOI":"10.1089\/can.2022.0335","volume":"9","author":"MA Elhendawy","year":"2024","unstructured":"Elhendawy MA, Radwan MM, Ibrahim EA, Wanas AS, Chandra S, Godfrey M, ElSohly MA. Validation and quantitation of fifteen cannabinoids in cannabis and marketed products using high-performance liquid chromatography-ultraviolet\/photodiode array method. Cannabis Cannabinoid Res. 2024;9(4):e1091\u2013107.","journal-title":"Cannabis Cannabinoid Res"},{"issue":"4","key":"3078_CR38","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1208\/s12249-012-9834-z","volume":"13","author":"NN Mohammed","year":"2012","unstructured":"Mohammed NN, Majumdar S, Singh A, Deng W, Murthy NS, Pinto E, et al. Klucel\u2122 EF and ELF polymers for immediate-release oral dosage forms prepared by melt extrusion technology. AAPS PharmSciTech. 2012;13(4):1158\u201369.","journal-title":"AAPS PharmSciTech"},{"key":"3078_CR39","doi-asserted-by":"publisher","first-page":"103505","DOI":"10.1016\/j.jddst.2022.103505","volume":"74","author":"S Omari","year":"2022","unstructured":"Omari S, Ashour EA, Elkanayati R, Alyahya M, Almutairi M, Repka MA. Formulation development of loratadine immediate- release tablets using hot-melt extrusion and 3D printing technology. J Drug Deliv Sci Technol. 2022;74:103505.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"3","key":"3078_CR40","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3390\/polym14030579","volume":"14","author":"R Munir","year":"2022","unstructured":"Munir R, Hadi A, Khan SD, Asghar S, Irfan M, Khan IU, et al. Solubility and Dissolution Enhancement of Dexibuprofen with Hydroxypropylbetacyclodextrin (HP\u03b2CD) and Poloxamers (188\/407) Inclusion Complexes: Preparation and In Vitro Characterization. Polymers. 2022;14(3):579.","journal-title":"Polymers."},{"issue":"10","key":"3078_CR41","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1002\/jps.20437","volume":"94","author":"S Prodduturi","year":"2005","unstructured":"Prodduturi S, Manek RV, Kolling WM, Stodghill SP, Repka MA. Solid-state stability and characterization of hot-melt extruded poly(ethylene oxide) films. J Pharm Sci. 2005;94(10):2232\u201345.","journal-title":"J Pharm Sci"},{"issue":"6","key":"3078_CR42","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.3390\/polym14061108","volume":"14","author":"YM Than","year":"2022","unstructured":"Than YM, Suriyarak S, Titapiwatanakun V. Rheological investigation of hydroxypropyl cellulose-based filaments for material extrusion 3D printing. Polymers. 2022;14(6):1108.","journal-title":"Polymers"},{"key":"3078_CR43","unstructured":"Size, Shape, and Other Physical Attributes of Generic Tablets and Capsules Guidance for Industry. 2022. Available from: https:\/\/www.fda.gov\/media\/161902\/download. Accessed 4 Mar 2025."},{"issue":"9","key":"3078_CR44","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.3390\/pharmaceutics14091787","volume":"14","author":"P Tabboon","year":"2022","unstructured":"Tabboon P, Pongjanyakul T, Limpongsa E, Jaipakdee N. In vitro release, mucosal permeation and deposition of cannabidiol from liquisolid systems: the influence of liquid vehicles. Pharmaceutics. 2022;14(9):1787.","journal-title":"Pharmaceutics"},{"issue":"8","key":"3078_CR45","doi-asserted-by":"publisher","first-page":"745","DOI":"10.3390\/pharmaceutics12080745","volume":"12","author":"TTD Tran","year":"2020","unstructured":"Tran TTD, Tran PHL. Molecular interactions in solid dispersions of poorly water-soluble drugs. Pharmaceutics. 2020;12(8):745.","journal-title":"Pharmaceutics"},{"issue":"8","key":"3078_CR46","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.1021\/ma100307m","volume":"43","author":"L Guo","year":"2010","unstructured":"Guo L, Sato H, Hashimoto T, Ozaki Y. FTIR study on hydrogen-bonding interactions in biodegradable polymer blends of Poly(3-hydroxybutyrate) and poly(4-vinylphenol). Macromolecules. 2010;43(8):3897\u2013902.","journal-title":"Macromolecules"},{"issue":"1","key":"3078_CR47","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ijpharm.2007.05.031","volume":"343","author":"M Newa","year":"2007","unstructured":"Newa M, Bhandari KH, Li DX, Kwon TH, Kim JA, Yoo BK, et al. Preparation, characterization and in vivo evaluation of ibuprofen binary solid dispersions with poloxamer 188. Int J Pharm. 2007;343(1):228\u201337.","journal-title":"Int J Pharm"},{"issue":"1","key":"3078_CR48","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1159\/000540353","volume":"7","author":"IE Taha","year":"2024","unstructured":"Taha IE, ElSohly MA, Radwan MM, Omari S, Repka MA, Ashour EA. Development and in vitro evaluation of cannabidiol mucoadhesive buccal film formulations using hot-melt extrusion technology. Med Cannabis Cannabinoids. 2024;7(1):171\u201382.","journal-title":"Med Cannabis Cannabinoids"},{"issue":"9","key":"3078_CR49","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3390\/ph13090219","volume":"13","author":"SA Millar","year":"2020","unstructured":"Millar SA, Maguire RF, Yates AS, O\u2019Sullivan SE. Towards Better Delivery of Cannabidiol (CBD). Pharmaceuticals. 2020;13(9):219.","journal-title":"Pharmaceuticals"},{"key":"3078_CR50","unstructured":"Klucel\u2122 Hydroxypropylcellulose.\u00a0https:\/\/www.ashland.com\/industries\/pharmaceutical\/oral-solid-dose\/klucel-hydroxypropylcellulose. Accessed 23 Jan 2025."},{"key":"3078_CR51","unstructured":"POLYOX\u2122 WSR N80.\u00a0https:\/\/www.industrialcellulosics.com\/products\/polyox\/polyox-wsr-n80. Accessed 23 Jan 2025."},{"key":"3078_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.103505","author":"S Omari","year":"2022","unstructured":"Omari S, Ashour EA, Elkanayati R, Alyahya M, Almutairi M, Repka MA. Formulation development of loratadine immediate- release tablets using hot-melt extrusion and 3D printing technology. J Drug Del Sci Technol. 2022. https:\/\/doi.org\/10.1016\/j.jddst.2022.103505.","journal-title":"J Drug Del Sci Technol"},{"issue":"8","key":"3078_CR53","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.3109\/10837450.2015.1089896","volume":"21","author":"X Zhang","year":"2016","unstructured":"Zhang X, Wang M, Li P, Wang A, Liang R, Gai Y, et al. Application of hot-melt extrusion technology for designing an elementary osmotic pump system combined with solid dispersion for a novel poorly water-soluble antidepressant. Pharm Dev Technol. 2016;21(8):1006\u201314.","journal-title":"Pharm Dev Technol"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03078-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-025-03078-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03078-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T18:03:05Z","timestamp":1748541785000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-025-03078-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":53,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["3078"],"URL":"https:\/\/doi.org\/10.1208\/s12249-025-03078-8","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,11]]},"assertion":[{"value":"20 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest regarding the publication of this paper. No financial support or other relationships that may pose a conflict were involved in the study or its preparation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"83"}}